List of studies with sex-specific outcomes
Study | Female/male | Interventions | Per cent stenosis | Outcome(s) assessed |
ECST11 | 850/2168 | CEA/BMT | 0%–99% | Model of stroke-free life expectancy stratified by age and per cent stenosis |
NASCET12 | 873/2012 | CEA/BMT | >70%; 50%–69%;<50% | 5-year risk of ipsilateral stroke stratified by per cent stenosis |
SPACE13 14 | 338/858 | CEA/CAS | >50% |
|
EVA-3S15 | 130/397 | CEA/CAS | >60% | 30-day risk of death, any stroke and 4-year risk of ipsilateral stroke (combined) |
CAVATAS16 | 152/352 | CEA/CAS | >60% | 8-year risk of any stroke or perioperative death (combined) |
ICSS17 | 503/1207 | CEA/CAS | >50% | 120-day risk of stroke, death or myocardial infarction (combined) |
CREST3 18 | 872/1630 | CEA/CAS | >50% >60% |
|
Pooled individual patient data meta-analysis | ||||
NASCET and ESCT4 5 | 1718/4175 | CEA/BMT | >50% |
|
EVA-3S, SPACE, ICSS, CREST trials9 | 1437/3317 | CEA/CAS | Multiple thresholds |
|
EVA-3S, SPACE, BACASS, ICSS, CREST trials10 | 1466/3395 | CEA/CAS | Multiple thresholds | 30-day risk of death or any stroke (combined) |
BACASS, Basel Carotid Artery Stenting Study; BMT, best medical therapy; CAS, carotid artery stenting; CAVATAS, Carotid And Vertebral Artery Transluminal Angioplasty Study; CEA, carotid endarterectomy; CREST, Carotid Revascularisation Endarterectomy Versus Stenting Trial; ECST, European Carotid Surgery Trial; EVA-3S, Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis; ICSS, International Carotid Stenting Study; NASCET, North American Symptomatic Carotid Endarterectomy Trial; SPACE, Stent-Supported Percutaneous Angioplasty of the Carotid Artery Versus Endarterectomy.